ALPS Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $745K | Sell |
56,798
-11,177
| -16% | -$147K | ﹤0.01% | 577 |
|
|
2025
Q1 | $1.5M | Sell |
67,975
-8,592
| -11% | -$189K | 0.01% | 392 |
|
|
2024
Q4 | $2.04M | Buy |
76,567
+7,661
| +11% | +$205K | 0.01% | 348 |
|
|
2024
Q3 | $1.84M | Sell |
68,906
-3,937
| -5% | -$105K | 0.01% | 372 |
|
|
2024
Q2 | $1.31M | Buy |
72,843
+7,171
| +11% | +$129K | 0.01% | 408 |
|
|
2024
Q1 | $1.2M | Buy |
65,672
+22,446
| +52% | +$409K | 0.01% | 430 |
|
|
2023
Q4 | $473K | Sell |
43,226
-3,648
| -8% | -$39.9K | ﹤0.01% | 614 |
|
|
2023
Q3 | $269K | Buy |
46,874
+361
| +0.8% | +$2.07K | ﹤0.01% | 903 |
|
|
2023
Q2 | $360K | Buy |
46,513
+4,834
| +12% | +$37.5K | ﹤0.01% | 703 |
|
|
2023
Q1 | $278K | Sell |
41,679
-1,227
| -3% | -$8.18K | ﹤0.01% | 945 |
|
|
2022
Q4 | $384K | Buy |
+42,906
| New | +$384K | ﹤0.01% | 690 |
|